产品说明书

Histamine 2HCl

Print
Chemical Structure| 56-92-8 同义名 : 组胺二盐酸盐 ;Ceplene;Histamine dihydrochloride
CAS号 : 56-92-8
货号 : A211645
分子式 : C5H11Cl2N3
纯度 : 98%
分子量 : 184.067
MDL号 : MFCD00012703
存储条件:

粉末 Keep in dark place,Sealed in dry,Room Temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(570.44 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Histamine dihydrochloride (Ceplene) is a synthetic derivative of the biogenic amine histamine. Histamine dihydrochloride inhibits the formation of reactive oxygen species (ROS) that suppress the activation of T cells and natural killer cells. Histamine dihydrochloride and IL-2 as maintenance therapy significantly prolonged LFS (longer leukaemia-free survival) compared with no treatment and had an acceptable tolerability profile in a large phase III trial in patients with AML (acute myeloid leukaemia)[3]. Clinical trials in solid tumors and in AML have demonstrated the potential to improve treatment outcome when histamine dihydrochloride is combined with immunotherapy[4]. In vitro ROS detection assays proved that the HDC (histamine dihydrochloride) loaded graphene nanoplatform could effectively inhibit ROS and thus prevent the immunosuppression caused by leukemic cells[5].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

5.43mL

1.09mL

0.54mL

27.16mL

5.43mL

2.72mL

54.33mL

10.87mL

5.43mL

参考文献

[1]Hornyak SC, Gehlsen KR, Haaparanta T. Histamine dihydrochloride protects against early alcohol-induced liver injury in a rat model. Inflammation. 2003 Oct;27(5):317-27.

[2]Agarwala SS, Sabbagh MH. Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment. Expert Opin Biol Ther. 2001 Sep;1(5):869-79.

[3]Yang LP, Perry CM. Histamine dihydrochloride: in the management of acute myeloid leukaemia. Drugs. 2011 Jan 1;71(1):109-22

[4]Perz JB, Ho AD. Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma. Future Oncol. 2008 Apr;4(2):169-77

[5]Cherukula K, Nurunnabi M, Jeong YY, Lee YK, Park IK. A targeted graphene nanoplatform carrying histamine dihydrochloride for effective inhibition of leukemia-induced immunosuppression. J Biomater Sci Polym Ed. 2018 May-Jun;29(7-9):734-749